What is Hims & Hers Health, Inc. worth?
With the base-case assumptions below, a discounted cash flow model on Hims & Hers Health, Inc.'s reported free cash flow gives $9.69 per share. The share price was $19.13 on November 10, 2026, 97% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 10.0% | 10.0% | $6.81 | -64% |
| Base | 15.0% | 9.0% | $9.69 | -49% |
| Bull | 20.0% | 8.0% | $15.06 | -21% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $11.87 | $12.55 | $13.38 | $14.42 | $15.76 |
| 8.0% | $10.23 | $10.67 | $11.20 | $11.82 | $12.59 |
| 9.0% | $9.04 | $9.34 | $9.69 | $10.10 | $10.58 |
| 10.0% | $8.14 | $8.35 | $8.59 | $8.87 | $9.19 |
| 11.0% | $7.43 | $7.59 | $7.76 | $7.96 | $8.18 |
Where the presets come from
Base: years 1 to 5 grow at Hims & Hers Health, Inc.'s revenue growth rate over the last 5 fiscal years (73.6% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions